These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3525764)

  • 1. Dose-response is alive and well.
    DeVita VT
    J Clin Oncol; 1986 Aug; 4(8):1157-9. PubMed ID: 3525764
    [No Abstract]   [Full Text] [Related]  

  • 2. Dose intensity: a critique of a critical review.
    Hryniuk WM
    J Clin Oncol; 1989 May; 7(5):681-4. PubMed ID: 2651583
    [No Abstract]   [Full Text] [Related]  

  • 3. Dose intensity in chemotherapy of metastatic breast cancer.
    J Clin Oncol; 1985 Jun; 3(6):889-91. PubMed ID: 3891924
    [No Abstract]   [Full Text] [Related]  

  • 4. More is better.
    Hryniuk WM
    J Clin Oncol; 1988 Sep; 6(9):1365-7. PubMed ID: 3047331
    [No Abstract]   [Full Text] [Related]  

  • 5. Scientific misconduct in cancer clinical trials.
    Vorobiof DA; Abratt R; Rapoport B; Ruff P; Slabber C; Goedhals L
    S Afr Med J; 2001 Aug; 91(8):614-5. PubMed ID: 11584765
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemotherapy for advanced aggressive lymphoma: more is better ...isn't it?
    Longo DL
    J Clin Oncol; 1990 Jun; 8(6):952-5. PubMed ID: 2189956
    [No Abstract]   [Full Text] [Related]  

  • 7. [Importance of dose intensity in chemotherapy--lessons from adjuvant chemotherapy for early breast cancer].
    Tamura K
    Rinsho Ketsueki; 2009 Apr; 50(4):276-81. PubMed ID: 19404020
    [No Abstract]   [Full Text] [Related]  

  • 8. [Aminoglutethimide in advanced breast cancer. Multicenter trial comparing 500 mg and 1000 mg per day].
    Bonneterre J; Coppens H; Mauriac L; Rouesse J; Fargeot P; Metz R; Armand JP; Mathieu A; Tubiana M; Cappelaere P
    Acta Clin Belg Suppl; 1986; 11():41-8. PubMed ID: 3521171
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of CAF versus CMFP in metastatic breast cancer: analysis of prognostic factors.
    Goodyear M
    J Clin Oncol; 1986 Mar; 4(3):442-4. PubMed ID: 3512787
    [No Abstract]   [Full Text] [Related]  

  • 10. [The use of high-dose chemotherapy in the treatment of breast cancer].
    Espinosa E; Zamora P; González Barón M
    Med Clin (Barc); 1996 Jun; 107(2):56-8. PubMed ID: 8753896
    [No Abstract]   [Full Text] [Related]  

  • 11. High-dose chemotherapy for advanced breast cancer.
    Ahmad K
    Lancet Oncol; 2006 Jan; 7(1):19. PubMed ID: 16408376
    [No Abstract]   [Full Text] [Related]  

  • 12. Evolving concepts in the systemic adjuvant treatment of breast cancer.
    Bonadonna G
    Cancer Res; 1992 Apr; 52(8):2127-37. PubMed ID: 1559216
    [No Abstract]   [Full Text] [Related]  

  • 13. Diffuse large-cell lymphoma: more CHOP-Bleo is not better.
    Coltman CA
    J Clin Oncol; 1986 Oct; 4(10):1439-40. PubMed ID: 2428946
    [No Abstract]   [Full Text] [Related]  

  • 14. Advances in cancer chemotherapy: lymphomas and breast cancer. December 5, 1896, San Francisco.
    Semin Hematol; 1987 Apr; 24(2 Suppl 1):1-69. PubMed ID: 3589705
    [No Abstract]   [Full Text] [Related]  

  • 15. High-dose chemotherapy for breast cancer: evolving data.
    Antman K; Tiersten A
    Oncology (Williston Park); 1999 Sep; 13(9):1215-9. PubMed ID: 10509318
    [No Abstract]   [Full Text] [Related]  

  • 16. [High dosage chemotherapy and peripheral blood stem cell transplantation in breast carcinoma].
    Jentsch-Ullrich K; Höffken HG; Franke A
    Zentralbl Chir; 1998; 123 Suppl 5():162-4. PubMed ID: 10063605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-response in the treatment of breast cancer: a critical review.
    Henderson IC; Hayes DF; Gelman R
    J Clin Oncol; 1988 Sep; 6(9):1501-15. PubMed ID: 3047340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Malignant lymphomas with initial breast localization. Experience of the Curie Institute].
    Langlois D; Natali JC; Laurent M; Pellier D; Vilcoq JR; Mazabraud A; Dumont J
    Bull Cancer; 1984; 71(2):108-10. PubMed ID: 6733291
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.
    Ahles TA; Saykin AJ; Furstenberg CT; Cole B; Mott LA; Skalla K; Whedon MB; Bivens S; Mitchell T; Greenberg ER; Silberfarb PM
    J Clin Oncol; 2002 Jan; 20(2):485-93. PubMed ID: 11786578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy dose and schedule in adjuvant treatment of breast cancer: phoenix, turkey, or dodo?
    Crown J
    Lancet; 2003 Aug; 362(9385):677-8. PubMed ID: 12957087
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.